GLOBUS MEDICAL

NYSE: GMED (Globus Medical, Inc.)

Last update: 5 days ago, 6:38AM

83.89

22.18 (35.94%)

Previous Close 61.71
Open 80.00
Volume 11,938,520
Avg. Volume (3M) 1,482,520
Market Cap 11,227,767,808
Price / Earnings (TTM) 27.15
Price / Earnings (Forward) 20.96
Price / Sales 4.23
Price / Book 2.58
52 Weeks Range
51.79 (-38%) — 94.93 (13%)
Earnings Date 6 Nov 2025
Profit Margin 7.39%
Operating Margin (TTM) 16.43%
Diluted EPS (TTM) 1.34
Quarterly Revenue Growth (YOY) -1.40%
Quarterly Earnings Growth (YOY) 76.30%
Total Debt/Equity (MRQ) 2.27%
Current Ratio (MRQ) 4.45
Operating Cash Flow (TTM) 645.55 M
Levered Free Cash Flow (TTM) 636.51 M
Return on Assets (TTM) 5.84%
Return on Equity (TTM) 4.63%

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Mixed Mixed
Medical Devices (Global) Mixed Bearish
Stock Globus Medical, Inc. Bullish Bearish

AIStockmoo Score

0.1
Analyst Consensus 1.5
Insider Activity -2.5
Price Volatility -0.5
Technical Moving Averages 0.0
Technical Oscillators 2.0
Average 0.10

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
GMED 11 B - 27.15 2.58
PEN 10 B - 63.68 8.06
GKOS 5 B - - 6.33
ITGR 2 B - 27.98 1.38
INSP 2 B - 44.87 3.57
AORT 2 B - - 4.56

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

Sector Healthcare
Industry Medical Devices
Investment Style Small Growth
% Held by Insiders 0.69%
% Held by Institutions 100.63%

Ownership

Name Date Shares Held
Hawk Ridge Capital Management Lp 30 Jun 2025 2,123,211
52 Weeks Range
51.79 (-38%) — 94.93 (13%)
Price Target Range
64.00 (-23%) — 114.00 (35%)
High 114.00 (Barclays, 35.89%) Buy
Median 91.50 (9.07%)
Low 64.00 (Stifel, -23.71%) Hold
Average 88.83 (5.89%)
Total 5 Buy, 1 Hold
Avg. Price @ Call 80.78
Firm Date Target Price Call Price @ Call
Barclays 10 Nov 2025 114.00 (35.89%) Buy 86.36
B of A Securities 07 Nov 2025 91.00 (8.48%) Buy 83.89
RBC Capital 07 Nov 2025 92.00 (9.67%) Buy 83.89
Truist Securities 07 Nov 2025 93.00 (10.86%) Buy 83.89
Wells Fargo 07 Nov 2025 79.00 (-5.83%) Buy 83.89
Stifel 28 Oct 2025 64.00 (-23.71%) Hold 62.75
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
RHOADS ANN D - 85.13 -10,000 -843,840
Aggregate Net Quantity -10,000
Aggregate Net Value ($) -843,840
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 85.13
Name Holder Date Type Quantity Price Value ($)
RHOADS ANN D Director 10 Nov 2025 Automatic sell (-) 2,000 86.36 172,720
RHOADS ANN D Director 07 Nov 2025 Automatic sell (-) 8,000 83.89 671,120

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria